TAOK2 and neurodegenerative disease: These include novel a-DMRs within the promoter of TAOK2 involved in the MAPK signalling pathway implicated in degenerative disease [56] (Additional file 3: Figure S1i) and within the promoter of an isoform of FADS2 associated with liver omega desaturation [57].